Search results
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 3 hours agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 4 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 2 hours agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 1 day agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill· 12 hours agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 3 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
Motley Fool via Yahoo Finance· 16 hours agoThis is admittedly not an ideal formula for growth. However, I think the worst is over for Pfizer's...
FDA clears GSK's RSV vaccine for adults ages 50-59
United Press International via Yahoo News· 5 hours agoThe U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WUSF 89.7· 19 hours agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...